Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7-30.

Howlader NA, Krapcho M, Miller D, et al. (eds.). SEER Cancer Statistics Review, 1975-2017, National Cancer Institute. Bethesda, USA.

Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567-78.

Taberna M, Oliva M, Mesia R. Cetuximab-containing combinations in locally advanced and recurrent or metastatic head and neck squamous cell carcinoma. Front Oncol 2019;9:383.

Ferris RL, Blumenschein G Jr., Fayette J, et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med 2016;375:1856-67.

Shin DS, Ribas A. The evolution of checkpoint blockade as a cancer therapy: what's here, what's next? Curr Opin Immunol 2015;33:23-35.

Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011;11:9-22.

Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005;103:1843-9.

Wu W, Wang Z, Zhou Z. Role of the human papillomavirus in malignant transformation of oral leukoplakia distinct from oropharyngeal squamous cell carcinoma: A study of 76 patients with internal-control specimens. Oral Surg Oral Med Oral Pathol Oral Radiol 2019;128:273-9.

Dediol E, Sabol I, Virag M, et al. HPV prevalence and p16INKa over-expression in non-smoking non-drinking oral cavity cancer patients. Oral Dis 2016;22:517-22.

Mirghani H, Amen F, Moreau F, St Guily JL. Do high-risk human papillomaviruses cause oral cavity squamous cell carcinoma? Oral Oncology 2015;51:229-36.

Lingen MW, Xiao W, Schmitt A, et al. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol 2013;49:1-8.

Zafereo ME, Xu L, Dahlstrom KR, et al. Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus. Oral Oncol 2016;56:47-53.

Cardesa A, Nadal A. Carcinoma of the head and neck in the HPV era. Acta Dermatovenerol Alp Pannonica Adriat 2011;20:161-73.

Boscolo-Rizzo P, Del Mistro A, Bussu F, et al. New insights into human papillomavirus-associated head and neck squamous cell carcinoma. Acta Otorhinolaryngol Ital 2013;33:77-87.

Creamer MR, Wang TW, Babb S, et al. Tobacco Product Use and Cessation Indicators Among Adults - United States, 2018. Centers for Disease Control and Prevention, Morbidity and Mortality Weekly Report. 2019;68:1013-19.

Myers JN ET, Roberts D, Byers RM. Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 2000;122:44-51

Patel SC, Carpenter WR, Tyree S, et al. Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol 2011;29:1488-94.

Pickering CR, Zhang J, Yoo SY, et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov 2013;3:770-81.

India Project Team of the International Cancer Genome C. Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. Nat Commun 2013;4:2873.

Cancer Genome Atlas N. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 2015;517:576-82.

DeAngelis A, Breik O, Koo K, et al. Non-smoking, non-drinking elderly females, a 5-year follow-up of a clinically distinct cohort of oral squamous cell carcinoma patients. Oral Oncol 2018;86:113-20.

Koo K, Barrowman R, McCullough M, et al. Non-smoking non-drinking elderly females: a clinically distinct subgroup of oral squamous cell carcinoma patients. Int J Oral Maxillofac Surg 2013;42:929-33.

Bachar G, Hod R, Goldstein DP, et al. Outcome of oral tongue squamous cell carcinoma in patients with and without known risk factors. Oral Oncol 2011;47:45-50.

Fan Y, Zheng L, Mao MH, et al. Survival analysis of oral squamous cell carcinoma in a subgroup of young patients. Asian Pac J Cancer Prev 2014;15:8887-91.

Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol 2015;8:11884-94.

Dahlstrom KR, Little JA, Zafereo ME, et al. Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study. Head Neck 2008;30:75-84.

Kruse AL, Bredell M, Gratz KW. Oral squamous cell carcinoma in non-smoking and non-drinking patients. Head Neck Oncol 2010;2:24.

Yesensky JA, Hasina R, Wroblewski KE, et al. Role of dental hardware in oral cavity squamous cell carcinoma in the low-risk nonsmoker nondrinker population. Head Neck 2018;40:784-92.

Paderno A, Morello R, Piazza C. Tongue carcinoma in young adults: a review of the literature. Acta Otorhinolaryngol Ital 2018;38:175-80.

Mascitti M, Tempesta A, Togni L, et al. Histological features and survival in young patients with HPV-negative oral squamous cell carcinoma. Oral Dis 2020;26:1640-8.

Wiseman SM, Swede H, Stoler DL, et al. Squamous cell carcinoma of the head and neck in nonsmokers and nondrinkers: an analysis of clinicopathologic characteristics and treatment outcomes. Ann Surg Oncol 2003;10:551-7.

Moyses RA, Lopez RV, Cury PM, et al. Significant differences in demographic, clinical, and pathological features in relation to smoking and alcohol consumption among 1,633 head and neck cancer patients. Clinics (Sao Paulo) 2013;68:738-44.

Farshadpour F, Hordijk GJ, Koole R, Slootweg PJ. Non-smoking and non-drinking patients with head and neck squamous cell carcinoma: a distinct population. Oral Dis 2007;13:239-43.

Tang YI, Liu Y, Zhao W, et al. Caspase-8 polymorphisms and risk of oral squamous cell carcinoma. Exp Ther Med 2015;10:2267-76.

Nishimoto IN, Pinheiro NA, Rogatto SR, et al. Cyclin D1 gene polymorphism as a risk factor for squamous cell carcinoma of the upper aerodigestive system in non-alcoholics. Oral Oncol 2004;40:604-10.

Qie S, Diehl JA. Cyclin D1, cancer progression, and opportunities in cancer treatment. J Mol Med (Berl) 2016;94:1313-26.

Nishiwaki T, Daigo Y, Kawasoe T, Nakamura Y. Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32. Genes Chromosomes Cancer 2000;27:169-76.

Huang YJ, Niu J, Wei S, et al. A novel functional DEC1 promoter polymorphism -249T>C reduces risk of squamous cell carcinoma of the head and neck. Carcinogenesis 2010;31:2082-90.

Tuna M, Amos CI, Mills GB. Genome-wide analysis of head and neck squamous cell carcinomas reveals HPV, TP53, smoking and alcohol-related allele-based acquired uniparental disomy genomic alterations. Neoplasia 2019;21:197-205.

Ebert BL. Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer. Leukemia 2009;23:1252-6.

Eisenmann KM, Dykema KJ, Matheson SF, et al. 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics. Oncogene 2009;28:3429-41.

Lu M, Liu Z, Yu H, et al. Combined effects of E2F1 and E2F2 polymorphisms on risk and early onset of squamous cell carcinoma of the head and neck. Mol Carcinog 2012;51:E132-41.

Pickering CR, Zhang J, Neskey DM, et al. Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokers. Clin Cancer Res 2014;20:3842-8.

Soares PO, Maluf Cury P, Mendoza Lopez RV, et al. GTSP1 expression in non-smoker and non-drinker patients with squamous cell carcinoma of the head and neck. PLoS One 2017;12:e0182600.

Lenouvel D, Gonzalez-Moles MA, Ruiz-Avila I, et al. Clinicopathological and prognostic significance of PD-L1 in oral cancer: A preliminary retrospective immunohistochemistry study. Oral Dis 2021;27:173-82.

Farshadpour F, Roepman P, Hordijk GJ, et al. A gene expression profile for non-smoking and non-drinking patients with head and neck cancer. Oral Dis 2012;18:178-83.

Farshadpour F, Hordijk GJ, Koole R, Slootweg PJ. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium. J Oral Pathol Med 2008;37:549-54.

Sorensen DM, Lewark TM, Haney JL,et al. Absence of p53 mutations in squamous carcinomas of the tongue in nonsmoking and nondrinking patients younger than 40 years. Arch Otolaryngol Head Neck Surg 1997;123:503-6.

Makarev E, Schubert AD, Kanherkar RR, et al. In silico analysis of pathways activation landscape in oral squamous cell carcinoma and oral leukoplakia. Cell Death Discov 2017;3:17022.

Zhang Q, Zhang J, Jin H, Sheng S. Whole transcriptome sequencing identifies tumor-specific mutations in human oral squamous cell carcinoma. BMC Med Genomics 2013;6:28.

Hsu PJ, Yan K, Shi H, et al. Molecular biology of oral cavity squamous cell carcinoma. Oral Oncol 2020;102:104552.

Saad MA, Kuo SZ, Rahimy E, et al. Alcohol-dysregulated miR-30a and miR-934 in head and neck squamous cell carcinoma. Mol Cancer 2015;14:181.

Wong TS, Man MW, Lam AK, et al The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR. Eur J Cancer 2003;39:1881-7.

Deschler DG, Richmon JD, Khariwala SS,et al. The "new" head and neck cancer patient-young, nonsmoker, nondrinker, and HPV positive: evaluation. Otolaryngol Head Neck Surg 2014;151:375-80.

Martin-Hernan F, Sanchez-Hernandez JG, Cano J, et alOral cancer, HPV infection and evidence of sexual transmission. Med Oral Patol Oral Cir Bucal 2013;18:e439-44.

Belobrov S, Angel C, Wiesenfeld D, McCullough M. Histopathological analysis of oral squamous cell carcinoma in nonsmokers and nondrinkers. Translational Research in Oral Oncology 2016.

Jelihovschi I, Bidescu AC, Tucaliuc SE, Iancu LS. Detection of human papilloma virus in head and neck squamous cell carcinomas: A literature review. Rev Med Chir Soc Med Nat Iasi 2015;119:502-9.

Tsimplaki E, Argyri E, Xesfyngi D, et al. Prevalence and expression of human papillomavirus in 53 patients with oral tongue squamous cell carcinoma. Anticancer Res 2014;34:1021-5.

Castellsague X, Alemany L, Quer M, et al. HPV involvement in head and neck cancers: Comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst 2016;108:djv403.

van Monsjou HS, van Velthuysen ML, van den Brekel MW, et al. Human papillomavirus status in young patients with head and neck squamous cell carcinoma. Int J Cancer 2012;130:1806-12.

Sano T, Oyama T, Kashiwabara K, et al. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998;153:1741-8.

Tomo S, Biss SP, Crivelini MM, et al. High p16(INK4a) immunoexpression is not HPV dependent in oral leukoplakia. Arch Oral Biol 2020;115:104738.

Poling JS, Ma XJ, Bui S, et al. Human papillomavirus (HPV) status of non-tobacco related squamous cell carcinomas of the lateral tongue. Oral Oncol 2014;50:306-10.

Foy JP, Bertolus C, Boutolleau D, et al. Arguments to support a viral origin of oral squamous cell carcinoma in non-smoker and non-drinker patients. Front Oncol 2020;10:822.

Perot P, Falguieres M, Arowas L, et al. Investigation of viral etiology in potentially malignant disorders and oral squamous cell carcinomas in non-smoking, non-drinking patients. PLoS One 2020;15:e0232138.

Ramos JC, Alves FA, Kowalski LP, et al. Epidemiological profile and clinical implications of oral squamous cell carcinoma adjacent to dental implants. Oral Dis 2021;27:1687-98.

Faccioni F, Franceschetti P, Cerpelloni M, Fracasso ME. In vivo study on metal release from fixed orthodontic appliances and DNA damage in oral mucosa cells. Am J Orthod Dentofacial Orthop 2003;124:687-93.

Vargas-Ferreira F, Nedel F, Etges A, et al. Etiologic factors associated with oral squamous cell carcinoma in non-smokers and non-alcoholic drinkers: a brief approach. Braz Dent J 2012;23:586-90.

Yan L, Chen F, He B, et al. A novel environmental exposure index and its interaction with familial susceptibility on oral cancer in non-smokers and non-drinkers: a case-control study. Eur Arch Otorhinolaryngol 2017;274:1945-50.

Chen F, Yan L, Lin L, et al. Independent and joint effects of tea and milk consumption on oral cancer among non-smokers and non-drinkers: a case-control study in China. Oncotarget 2017;8:50091-7.

Chen Q, Wang J, Wang J, et al. Erythrocyte omega-3 polyunsaturated fatty acids are inversely associated with the risk of oral cancer: a case-control study. Nutr Diabetes 2020;10:35.

Lenouvel D, Gonzalez-Moles MA, Ruiz-Avila I, et al. Prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma: A systematic review and comprehensive meta-analysis. Oral Oncol 2020;106:104722.

Santos-Silva AR, Carvalho Andrade MA, Jorge J, et al. Tongue squamous cell carcinoma in young nonsmoking and nondrinking patients: 3 clinical cases of orthodontic interest. Am J Orthod Dentofacial Orthop 2014;145:103-7.

Jovanovic A, Schulten EA, Kostense PJ, et al. Tobacco and alcohol related to the anatomical site of oral squamous cell carcinoma. J Oral Pathol Med 1993;22:459-62.

Campbell BH, Mark DH, Soneson EA, et al. The role of dental prostheses in alveolar ridge squamous carcinomas. Arch Otolaryngol Head Neck Surg 1997;123:1112-5.

Sim YC, Hwang JH, Ahn KM. Overall and disease-specific survival outcomes following primary surgery for oral squamous cell carcinoma: analysis of consecutive 67 patients. J Korean Assoc Oral Maxillofac Surg 2019;45:83-90.

Durr ML, van Zante A, Li D, et al. Oral tongue squamous cell carcinoma in never-smokers: analysis of clinicopathologic characteristics and survival. Otolaryngol Head Neck Surg 2013;149:89-96.

Descamps G, Karaca Y, Lechien JR, et al. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients. J Cancer Res Clin Oncol 2016;142:2185-96.

Bao X, Liu F, Chen Q, et al. Propensity score analysis exploring the impact of smoking and drinking on the prognosis of patients with oral cancer. Head Neck 2020;42:1837-47.

Best DL, Herzog C, Powell C, et al. Oral lichen planus-associated oral cavity squamous cell carcinoma is associated with improved survival and increased risk of recurrence. J Oral Maxillofac Surg 2020;78:1193-202.

Gu X, Coates PJ, Boldrup L, et al. Copy number variation: A prognostic marker for young patients with squamous cell carcinoma of the oral tongue. J Oral Pathol Med 2019;48:24-30.

Rock LD, Rosin MP, Zhang L, et al. Characterization of epithelial oral dysplasia in non-smokers: First steps towards precision medicine. Oral Oncol 2018;78:119-25.

Yang Z, Du W, Zhang X, et al. Non-smoking and non-drinking oral squamous cell carcinoma patients: A different entity. Front Oncol 2021;11:558320.

Adeoye J, Hui L, Tan JY, et al. Prognostic value of non-smoking, non-alcohol drinking status in oral cavity cancer. Clin Oral Investig 2021.

Koo K. Genomic Signature of Oral Squamous Cell Carcinomas from Non-Smoking Non-Drinking Patients. 2021;25:6909-18.

Brennan K, Koenig JL, Gentles AJ, et al. Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype. EBioMedicine 2017;17:223-36.

Foy JP, Bertolus C, Michallet MC, et al. The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade. Ann Oncol 2017;28:1934-41.

Albuquerque R, Lopez-Lopez J, Mari-Roig A, et al. Oral tongue squamous cell carcinoma (OTSCC): alcohol and tobacco consumption versus non-consumption. A study in a Portuguese population. Braz Dent J 2011;22:517-21.